title: Increased levels of sTNF receptors following OKT3 treatment.
authors.affiliation: Renal Transplant and Clinical Immunology Unit, Academic Medical Centre, Amsterdam, The Netherlands.
authors.forename: F J
authors.initials: FJ
authors.lastname: Bemelman
authors.forename: J
authors.initials: J
authors.lastname: Jansen
authors.forename: T
authors.initials: T
authors.lastname: van der Poll
authors.forename: C E
authors.initials: CE
authors.lastname: Hack
authors.forename: S J
authors.initials: SJ
authors.lastname: van Deventer
authors.forename: R J
authors.initials: RJ
authors.lastname: ten Berge
mesh_terms: D015415:Biomarkers / Q000097:blood; D006084:Graft Rejection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000032:analysis / Q000378:metabolism*; D013997:Time Factors
chemical_list: D015415:Biomarkers; D016853:Muromonab-CD3; D018124:Receptors, Tumor Necrosis Factor; D008775:Methylprednisolone